TCE-RRMM

Clinical trials for TCE-RRMM explained in plain language.

Never miss a new study

Get alerted when new TCE-RRMM trials appear

Sign up with your email to follow new studies for TCE-RRMM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Tracking a new hope for Tough-to-Treat blood cancer patients

Disease control Not yet recruiting

This study aims to collect real-world information on how well the drug elranatamab works for Chinese patients with advanced multiple myeloma that has stopped responding to other standard treatments. It will follow about 159 patients who are already receiving this drug as part of …

Matched conditions: TCE-RRMM

Sponsor: Peking University People's Hospital • Aim: Disease control

Last updated Mar 25, 2026 14:08 UTC

TCE-RRMM

Get alerted when new TCE-RRMM trials appear

Tracking a new hope for Tough-to-Treat blood cancer patients